# Yizhun-ai.com

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/yizhun-ai-com

- Industry: Healthcare
- Headquarters: Beijing, China
- Website: www.yizhun-ai.com
- Total disclosed funding: $37M
- Latest round: Series C (Jun 21, 2021)
- Investors on record: 9

## About

Based in Beijing, China and established in 2017, Yizhun-ai.com is a medical service provider that focuses on providing medical imaging diagnosis services bases on AI technology. In 2018, the company launched the pulmonary nodule intelligent inspection system V1.0. In 2019, it released Darwin Intelligent Research Platform 1.0. In 2020, the company released the new coronary pneumonia intelligent analysis system. The company’s partners include Beijing Hospital, Beijing Cancer Hospital, Shanghai Huadong Hospital, etc.

The company's products include chest CT intelligent analysis system, chest DR analysis system, breast ultrasound intelligent analysis system, breast X-ray intelligent analysis system and intelligent scientific research platform, providing intelligent analysis solutions from screening, management to diagnostic analysis.

## Funding rounds

- Series C, Jun 21, 2021 — Sharewin Investment, Yijing Investment, BioTrack Capital
- Series B, Feb 24, 2021, $15M — Sanmei Capital, CITIC Med Fund
- Series B, Mar 19, 2020, $14M — Hina Group, Qingsong Fund, Sanmei Capital, Langcheng Capital
- Series A, Nov 6, 2018, $6.5M — Hina Group
- Angel, Dec 1, 2017, $0.9M — AA Investment

## Investors

- AA Investment (https://capitalatlas.ai/funds/aa-investment) — Angel
- Hina Group (https://capitalatlas.ai/funds/hina-group) — Series A, Series B
- Qingsong Fund (https://capitalatlas.ai/funds/qingsong-fund) — Series B
- Sanmei Capital (https://capitalatlas.ai/funds/sanmei-capital) — Series B
- Langcheng Capital (https://capitalatlas.ai/funds/langcheng-capital) — Series B
- CITIC Med Fund (https://capitalatlas.ai/funds/citic-med-fund) — Series B
- Sharewin Investment (https://capitalatlas.ai/funds/sharewin-investment) — Series C
- Yijing Investment (https://capitalatlas.ai/funds/yijing-investment) — Series C
- BioTrack Capital (https://capitalatlas.ai/funds/biotrack-capital) — Series C